Oncolytics Biotech
ONCY
#9651
Rank
NZ$0.17 B
Marketcap
NZ$1.43
Share price
-3.60%
Change (1 day)
-30.40%
Change (1 year)

Oncolytics Biotech (ONCY) - Total debt

Total debt on the balance sheet as of March 2026 : NZ$0.87 Million

According to Oncolytics Biotech 's latest financial reports the company's total debt is NZ$0.87 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Oncolytics Biotech - Total debt on balance sheet (from 2000 to 2026)

Total debt by year

Year Total debt Change
2025-12-31NZ$0.97 M-27.96%
2024-12-31NZ$1.34 M167.62%
2023-12-31NZ$0.5 M16.48%
2022-12-31NZ$0.43 M-42.45%
2021-12-31NZ$0.75 M72.11%
2020-12-31NZ$0.43 M-24.07%
2019-12-31NZ$0.57 M
2018-12-31N/A
2006-12-31NZ$0.18 M-3.33%
2005-12-31NZ$0.18 M8.06%
2004-12-31NZ$0.17 M-1.73%
2003-12-31NZ$0.17 M-2.26%
2002-12-31NZ$0.18 M-19.76%
2001-12-31NZ$0.22 M0.52%
2000-12-31NZ$0.22 M13.9%
1999-12-31NZ$0.19 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Eli Lilly
LLY
NZ$74.78 B 8,537,301.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$80.06 B 9,139,270.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
NZ$86.6 M 9,786.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
NZ$2.9 M 232.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$29.15 B 3,328,049.61%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
NZ$66.69 M 7,514.17%๐Ÿ‡บ๐Ÿ‡ธ USA